Implementation of cardiovascular prevention guidelines in clinical practice. Results from the POLASPIRE II survey.
Background: There is limited knowledge about the implementation of current guidelines in every- day clinical practice. Aim: To describe risk factors management in patients with coronary artery disease through lifestyle modifications and the use of drug therapies to provide an objective assessment of...
| Publicado en: | Polish Heart Journal / Kardiologia Polska Vol. 83; no. 5; pp. 577 - 585 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
VM Medica-VM Group (Via Medica)
2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185509391&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 185509391 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00229032 1CZM jtl: Polish Heart Journal / Kardiologia Polska issn: 00229032 maglogo: N pubinfo: dt: 2025 vid: 83 iid: 5 pid: 21698 pub: VM Medica-VM Group (Via Medica) artinfo: ui: 185509391 185509391 185509391 10.33963/v.phj.103434 185509391 ppf: 577 ppct: 8 formats: tig: atl: Implementation of cardiovascular prevention guidelines in clinical practice. Results from the POLASPIRE II survey. aug: au: Jankowski, Piotr Koczwarska-Maciejek, Dominika Kamiński, Karol Gąsior, Zbigniew Kosior, Dariusz A. Styczkiewicz, Marek Kubica, Aldona Rajzer, Marek Charkiewicz-Szeremeta, Katarzyna Dąbek, Józefa Kulak, Piotr Michalski, Piotr Łapińska, Magda Maciejewski, Łukasz Kosobucka-Ozdoba, Agata Wolfshaut-Wolak, Renata Burzyńska, Monika Pająk, Andrzej Kotseva, Kornelia McEvoy, John William affil: Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warszawa, Poland sug: subj: Cardiovascular Diseases Prevention and Control Cardiovascular Risk Factors Prevention and Control Coronary Arteriosclerosis Drug Therapy Guideline Adherence Life Style Changes Implementation Science Human Descriptive Statistics Male Female Aged Angiotensin-Converting Enzyme Therapeutic Use Fibrinolytic Agents Therapeutic Use Adrenergic beta-Antagonists Therapeutic Use Poland Aged, 80 and Over Aged: 65+ years Aged, 80 & over Male Female ab: Background: There is limited knowledge about the implementation of current guidelines in every- day clinical practice. Aim: To describe risk factors management in patients with coronary artery disease through lifestyle modifications and the use of drug therapies to provide an objective assessment of the implementation of the current guidelines on cardiovascular prevention. Methods: Twelve departments of cardiology in 6 regions participated in the study (conducted in 2022-2023). Patients (aged ≤80 years) were recruited and interviewed 6-18 months following hospitalization due to an acute coronary syndrome (68.7%) or a myocardial revascularization procedure (31.3%). Results: A total of 801 patients (median age 66.4 years, 595 men and 206 women) were examined. The proportion of patients with high blood pressure was 66.5%, with high low-density lipoprotein cholesterol 79.8%, and with high HbA1c 16.0%; 19.5% of participants were active smokers, and 80.5% were overweight/obese. The proportion of patients taking at least one antiplatelet/antithrombotic agent was 92.8%, a β-blocker 84.7%, an angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker 79.8%, and a lipid-lowering drug 89.5% patients. Only 8.6% patients had all the 5 main risk factors well controlled, while 2.4% had all risk factors at recommended target and were prescribed an antiplatelet or an antithrombotic drug and an angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker. Conclusions: There is considerable opportunity of further reduction of cardiovascular risk in Polish patients treated for coronary artery disease. A revision of the ongoing and more intensive endorsement of cardiovascular prevention programs is advisable. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|